Publicacións (35) Publicacións de María José Rodríguez Cid

2024

  1. Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration

    Ophthalmology Retina, Vol. 8, Núm. 4, pp. 350-359

  2. Relationships between Patient-Reported Outcome Measures and Clinical Measures in Naïve Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Ranibizumab

    Pharmaceuticals, Vol. 17, Núm. 2

  3. The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration

    Pharmaceutics, Vol. 16, Núm. 1

2023

  1. Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration

    Investigative ophthalmology & visual science, Vol. 64, Núm. 13, pp. 34

2022

  1. The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world

    Acta ophthalmologica, Vol. 100, Núm. 2, pp. e521-e531

2021

  1. Recomendaciones «no hacer» para retinopatías: estudio mixto de consenso

    Archivos de la Sociedad Española de Oftalmologia, Vol. 96, Núm. 11, pp. 578-586

2020

  1. Características clínicas, manejo y resultados de los pacientes con endoftalmitis estéril asociados con la inyección intravítrea de factores de crecimiento endotelial antivascular

    Archivos de la Sociedad Española de Oftalmologia, Vol. 95, Núm. 5, pp. 211-216

  2. Pharmacological advances in the treatment of age-related macular degeneration

    Current Medicinal Chemistry, Vol. 27, Núm. 4, pp. 583-598

2018

  1. A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS)

    Acta Ophthalmologica, Vol. 96, Núm. 8, pp. e942-e949

  2. Ultrasonographic findings in the vitreous of patients with age-related macular degeneration treated with intravitreal anti-vascular endothelial growth factor injections

    Retina, Vol. 38, Núm. 10, pp. 1962-1967

2014

  1. Bevacizumab intravítreo como tratamiento de las telangiectasias yuxtafoveales idiopáticas tipo I

    Archivos de la Sociedad Española de Oftalmologia, Vol. 89, Núm. 7, pp. 269-271

  2. Síndrome de Kearns-Sayre: manifestaciones oftalmológicas

    Anales de Pediatria, Vol. 82, Núm. 1, pp. e151-e153

2013

  1. Further development of forensic eye color predictive tests

    Forensic Science International: Genetics, Vol. 7, Núm. 1, pp. 28-40

2008

  1. Síndrome de Vogt Koyanagi Harada

    Archivos de la Sociedad Española de Oftalmologia, Vol. 83, Núm. 6, pp. 385-389

2006

  1. Combined Photodynamic Therapy and Intravitreal Triamcinolone Acetonide for the Treatment of Myopic Subfoveal Choroidal Neovascularization

    American Journal of Ophthalmology, Vol. 142, Núm. 2, pp. 335-337

2003

  1. Response to Gómez-ulla et al. [17] (multiple letters)

    Diabetes Care

2002

  1. Digital retinal images and teleophthalmology for detecting and grading diabetic retinopathy

    Diabetes Care, Vol. 25, Núm. 8, pp. 1384-1389

  2. Scanning laser ophthalmoscope findings in acute macular neuroretinopathy

    Retina, Vol. 22, Núm. 1, pp. 108-109

2001

  1. Bone marrow transplantation retinopathy

    International Ophthalmology, Vol. 24, Núm. 1, pp. 33-35

  2. Diode laser photocoagulation of choroidal neovascularization associated with retinal pigment epithelial detachment

    Acta Ophthalmologica Scandinavica, Vol. 79, Núm. 1, pp. 39-44